Brannan JJ[au] - Search Results

Year	Number of Results
1979	2
1980	2
1983	1
1984	1
1986	1
1992	1
1994	1
1995	1
1996	1
2001	1
2022	0

1

Cerebral monitoring during cardiopulmonary bypass.

Ali MI, Smith PL, Brannan JJ, Taylor KM. Ali MI, et al. Among authors: brannan jj. Perfusion. 1996 Jul;11(4):299-312. doi: 10.1177/026765919601100402. Perfusion. 1996. PMID: 8884858 Review. No abstract available.

2

Effect of prostacyclin PGI2 on cardiopulmonary bypass-induced lung injury.

Fessatidis IT, Brannan JJ, Taylor KM, Kanellaki-Kyparissi M, Abdulla AK, Olsen EC. Fessatidis IT, et al. Among authors: brannan jj. Perfusion. 1994 Jan;9(1):23-33. doi: 10.1177/026765919400900105. Perfusion. 1994. PMID: 8161864

3

Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass.

Taylor KM, Bain WH, Russell M, Brannan JJ, Morton IJ. Taylor KM, et al. Among authors: brannan jj. Thorax. 1979 Oct;34(5):594-8. doi: 10.1136/thx.34.5.594. Thorax. 1979. PMID: 515979 Free PMC article.

4

Thrombotic obstruction of the Björk-Shiley valve: the Glasgow experience.

Ryder SJ, Bradley H, Brannan JJ, Turner MA, Bain WH. Ryder SJ, et al. Among authors: brannan jj. Thorax. 1984 Jul;39(7):487-92. doi: 10.1136/thx.39.7.487. Thorax. 1984. PMID: 6463927 Free PMC article.

5

Assessment of cerebral damage during open-heart surgery. A new experimental model.

Taylor KM, Devlin BJ, Mittra SM, Gillan JG, Brannan JJ, McKenna JM. Taylor KM, et al. Among authors: brannan jj. Scand J Thorac Cardiovasc Surg. 1980;14(2):197-203. doi: 10.3109/14017438009100997. Scand J Thorac Cardiovasc Surg. 1980. PMID: 7433939

6

Haemodynamic effects of angiotensin converting enzyme inhibition after cardiopulmonary bypass in dogs.

Taylor KM, Casals JG, Mittra SM, Brannan JJ, Morton JJ. Taylor KM, et al. Among authors: brannan jj. Cardiovasc Res. 1980 Apr;14(4):199-205. doi: 10.1093/cvr/14.4.199. Cardiovasc Res. 1980. PMID: 6253069

7

Role of angiotensin II in the development of peripheral vasoconstriction during cardiopulmonary bypass.

Taylor KM, Brannan JJ, Bain WH, Caves PK, Morton IJ. Taylor KM, et al. Among authors: brannan jj. Cardiovasc Res. 1979 May;13(5):269-73. doi: 10.1093/cvr/13.5.269. Cardiovasc Res. 1979. PMID: 476747

8

A genetically engineered human Kunitz protease inhibitor with increased kallikrein inhibition in an ovine model of cardiopulmonary bypass.

Ohri SK, Parratt R, White T, Becket J, Brannan JJ, Hunt BJ, Taylor KM. Ohri SK, et al. Among authors: brannan jj. Perfusion. 2001 May;16(3):199-206. doi: 10.1177/026765910101600305. Perfusion. 2001. PMID: 11419655 Clinical Trial.

9

The United Kingdom Heart Valve Registry.

Taylor KM, Gray SA, Livingstone S, Brannan JJ. Taylor KM, et al. Among authors: brannan jj. J Heart Valve Dis. 1992 Nov;1(2):152-9. J Heart Valve Dis. 1992. PMID: 1341622

10

The effect of methylprednisolone pre-treatment on brain damage in dogs during cardiopulmonary bypass. A double blind study.

Taylor KM, Dawson H, Desai J, Jamieson MP, Brannan JJ, McKenna J. Taylor KM, et al. Among authors: brannan jj. J Cardiovasc Surg (Torino). 1983 Nov-Dec;24(6):622-7. J Cardiovasc Surg (Torino). 1983. PMID: 6654973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results